Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Ziyi Yang, Yimin Yan
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Obesity
Online Access:https://onlinelibrary.wiley.com/doi/10.1002/oby.24142
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1002/oby.24142

Similar Items

  • Response to “The safety of semaglutide in patients with depression and obesity”
    by: Robert F. Kushner, et al.
    Published: (2024)
  • A GLP1R gene variant and sex influence the response to semaglutide treatment in patients with severe obesity
    by: Aurélie Phan, et al.
    Published: (2025)
  • Comment on “Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes”
    by: Manish R. Bhise, et al.
    Published: (2025)
  • Potent incretin‐based therapy for obesity: A systematic review and meta‐analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety
    by: Alberte Laura Oest Müllertz, et al.
    Published: (2024)
  • Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
    by: Jason M. Samuels, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs